Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-06-26
1981-12-08
Cacciapaglia, Jr., Frank
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424362, A61K 3154, A61K 4700
Patent
active
043047734
ABSTRACT:
New bendroflumethiazide formulations in solid form are provided which are characterized by excellent disintegration and dissolution capabilities even after long periods of storage. The new bendroflumethiazide formulations, for example, in the form of tablets, contain in addition to bendroflumethiazide, a combination of microcrystalline cellulose which serves as a diluent and aids in disintegration of the tablets, lactose which serves as a diluent, optionally starch (in the gelatinized form) which serves as a disintegrant, and one or more auxilliary disintegrants, such as sodium carboxymethyl starch, a tablet lubricant, such as magnesium stearate, and a colorant, if desired.
A method for preparing the above formulations is also provided.
REFERENCES:
patent: 3265573 (1966-08-01), Goldberg
Merck Index, 9th Ed., 1976, entry no. 1042.
Lachman et al., "The Theory & Practice of Industrial Pharmacy", 2nd Ed. (1976), pp. 325-333.
Patel Mahendra R.
Wong Thomas M.
Cacciapaglia, Jr. Frank
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Rodney Burton
LandOfFree
Novel bendroflumethiazide formulations and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel bendroflumethiazide formulations and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel bendroflumethiazide formulations and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-567816